21PBaseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab. (17th December 2018)

Record Type:: Journal Article
Title:: 21PBaseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab. (17th December 2018)
Main Title:: 21PBaseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab
Authors:: Awada, G
Özdemir, I
Schwarze, J K
Daeninck, E
Gondry, O
Jansen, Y
Seremet, T
Keyaerts, M
Everaert, H
Neyns, B
Abstract:
Is Part Of:: Annals of oncology. Volume 29(2018)Supplement 10
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 10
Issue Display:: Volume 29, Issue 10 (2018)
Year:: 2018
Volume:: 29
Issue:: 10
Issue Sort Value:: 2018-0029-0010-0000
Page Start:
Page End:
Publication Date:: 2018-12-17
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdy493.019 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12263.xml